Alan Baer Maderazo, VP, Qual, Reg, & Clin Affairs at GenMark Diagnostics, Inc. (GNMK), sold 1,233 shares at $19.12 ($3K) on 2021-02-24, disclosed to the SEC on 2021-02-24.
Scheduled sale ($3k) by VP, Qual, Reg, & Clin Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,070 | $0 | 0.0% |
| 2 | $19.12 | 163 | $3K | 100.0% |
| Total | $2.53 avg | 1,233 | $3K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-22 | $6K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $189K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $676K | — | Filing → |